Company Search:
Advanced Search
Sponsored Links
Capstone Therapeutics Corp Company Snapshot
Capstone Therapeutics Corp operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Capstone Therapeutics Corp with three other companies in this sector in the United States: Medicines Company (The) (2002 sales of $38.30 million of which 100% was Development of Drugs), Array BioPharma Inc. ($35.09 million of which 96% was Collaboration revenue), and Lexicon Pharmaceuticals Incorporated ($35.20 million of which 100% was Pharmaceutical R&D).

Sales Analysis. During the year ended December of 2002, sales at Capstone Therapeutics Corp were $40.39 million. This is a sharp decrease of 35.2% versus 2001, when the company's sales were $62.36 million.
  Stock Performance Chart for Capstone Therapeutics Corp
  Stock Data: Recent Stock Performance:
  Current Price (1/11/2018): .05
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks -10.0%  
4 Weeks -18.2%   52 Weeks -52.6%  
Capstone Therapeutics Corp Key Data:
  Ticker: CAPS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2002 Sales 40,389,000
(Year Ending Jan 2003).
Employees: 2
  Currency: U.S. Dollars Market Cap: 2,447,343
  Fiscal Yr Ends: December Shares Outstanding: 54,385,411
  Share Type: Common Closely Held Shares: 27,522,597
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.